SIC
CRMD icon

Salem Investment Counselors’s CorMedix CRMD Stock Holding History

Salem Investment Counselors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,500
Closed -$21.8K – 1125
2023
Q2 		$21.8K Buy
+5,500
New +$27.2K ﹤0.01% 676

Other funds holding CRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Salem Investment Counselors's CRMD Position: Q3 2023 in Review

Salem Investment Counselors sold out of CorMedix (CRMD) in Q3 2023, closing a stake of 5,500 shares — an estimated $21.8K sold.

Salem Investment Counselors first reported a position in CRMD in Q2 2023 and held it in 1 quarter. The position peaked at $21.8K in Q2 2023. 92 funds tracked by Wall St. Rank hold CRMD as of Q3 2023.

  • Salem Investment Counselors reported no remaining CorMedix position as of Q3 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 5,500 CorMedix shares in Q3 2023, an estimated $21.8K.
  • Salem Investment Counselors first reported a position in CorMedix in Q2 2023 and held it in 1 quarter.
  • Salem Investment Counselors's CorMedix position peaked at $21.8K in Q2 2023.
  • 92 funds tracked by Wall St. Rank held CorMedix as of Q3 2023.

Based on Salem Investment Counselors's 13F filing for Q3 2023, filed 4 Oct 2023.